FDA — authorised 30 January 2009
- Application: NDA022287
- Marketing authorisation holder: TAKEDA PHARMS USA
- Local brand name: DEXILANT
- Indication: CAPSULE, DELAYED RELEASE — ORAL
- Status: approved
🇺🇸 Dexlansoprazole MR in United States
FDA authorised Dexlansoprazole MR on 30 January 2009
Marketing authorisation
Other Gastroenterology approved in United States
Frequently asked questions
Is Dexlansoprazole MR approved in United States?
Yes. FDA authorised it on 30 January 2009.
Who is the marketing authorisation holder for Dexlansoprazole MR in United States?
TAKEDA PHARMS USA holds the US marketing authorisation.